CPT code 68510 covers a diagnostic surgical biopsy of the lacrimal gland with submission of the specimen for pathologic examination. This procedure provides tissue diagnosis for inflammatory, infectious, and neoplastic conditions affecting the lacrimal gland and adjacent orbital structures. Nationally, accurate coding and documentation for lacrimal gland biopsy matter for clinical communication, utilization tracking, and appropriate billing across diverse payer policies. Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will find a concise overview of the clinical context for lacrimal gland biopsy, expected sites of service, and the common modifiers associated with procedural reporting. The publication summarizes typical coverage considerations and coding practice patterns, presents benchmark metrics where available, and highlights recent policy updates affecting hospital outpatient and ambulatory surgical settings. The content is intended to help revenue cycle and clinical teams understand the coding intent, documentation needs, and payer landscape relevant to CPT code 68510 at a national level.